3D Body Scanning Is Here, and It Could Change How You See Yourself

| October 12, 2018

article image
“The idea is that, eventually, these detailed scans might help with diagnosing and monitoring cancers, bone diseases, or blood vessel problems. Other research groups have been using them in labs around the world like to image tiny kidney stones, for example. But they’re not being used in hospitals yet.”

Spotlight

Pathology Laboratories, Inc.

Established in Toledo, Ohio in 1946, Pathology Laboratories, Inc. (PathLabs) fostered a reputation among the area’s private medical practitioners as a provider of prompt, reliable and convenient laboratory testing services. Its status as a key partner in the delivery of quality medical care to the community was advanced in 1970 when PathLabs became the first independent medical laboratory in Ohio to seek and attain accreditation by the College of American Pathologists - the preeminent laboratory certifying body in the nation. Over the ensuing decades, PathLabs continued its tradition of uncompromising quality, personal service and overall excellence to become the dominant full-service independent medical laboratory in northwest Ohio and southeast Michigan. Since 2004, we have rapidly expanded our operations to other areas of Ohio including Cleveland, Columbus and Lima and their surrounding communities.

OTHER ARTICLES

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | March 11, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

Spotlight

Pathology Laboratories, Inc.

Established in Toledo, Ohio in 1946, Pathology Laboratories, Inc. (PathLabs) fostered a reputation among the area’s private medical practitioners as a provider of prompt, reliable and convenient laboratory testing services. Its status as a key partner in the delivery of quality medical care to the community was advanced in 1970 when PathLabs became the first independent medical laboratory in Ohio to seek and attain accreditation by the College of American Pathologists - the preeminent laboratory certifying body in the nation. Over the ensuing decades, PathLabs continued its tradition of uncompromising quality, personal service and overall excellence to become the dominant full-service independent medical laboratory in northwest Ohio and southeast Michigan. Since 2004, we have rapidly expanded our operations to other areas of Ohio including Cleveland, Columbus and Lima and their surrounding communities.

Events